Hoffmann-La Roche Ltd has committed "several million dollars" to CDRC Ventures Inc (CVI) — the commercial arm of the Centre for Drug Research and Development — to develop health research technologies under the direction of CVI. Hoffmann and CVI will jointly determine the intellectual property paths for the projects as well as assess opportunities for collaboration, funding, management and commercialization of the technologies....